Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06658808 · ClinicalTrials.gov registry record · NA
Efficacy-Implementation Study for PC CARES in Rural Alaska
A NA study of Suicide Prevention, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 1,075
- Enrollment target
- 2
- Study locations
NCT06658808: Recruiting NA study of Suicide Prevention, sponsored by University of Michigan.
NCT06658808 is a NA study of Suicide Prevention that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 1,075 participants, above the 901-participant average among 21 other Suicide Prevention trials with a reported enrollment target (19% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06658808, a NA study of Suicide Prevention, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,075 participants
- Enrollment target
- 2
- Study locations
Study Summary
This participatory, pragmatic efficacy-implementation trial evaluates the impact of Promoting Community Conversations About Research to End Suicide (PC CARES) to evaluate Learning Circle (LC) participant outcomes (AIM#1), community-wide diffusion effects, and efficacy by tracking youth impact (AIM#2), while finding sustainable ways to scale PC CARES to other Alaska Native (AN) communities (AIM#3).
Primary Outcome
Collaborations for a community of practice (CoP) related to wellness promotion and suicide prevention are measured on a 7-point Agreement Scale (3 survey questions). Change in CoP is measured in adult intervention and non-intervention participants.
Conditions Studied
Interventions
- BEHAVIORAL Promoting Community Conversations About Research to End Suicide
Study Locations (2)
Alaska
- Rural Human Services Program - Fairbanks
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,075 participants |
| Start Date | 2024-09-12 |
| Est. Completion | 2031-05 |
| Phase | NA |
What NCT06658808 shows while recruiting
NCT06658808 is an interventional study that assigns participants to a tested intervention. Its 1,075 participants enrollment target places it among the larger protocols in the corpus, above the 901-participant average among 21 other Suicide Prevention trials with a reported enrollment target (19% higher).
The record links to 1 condition, with Suicide Prevention appearing as the primary indexed condition, and to 1 intervention - of which Promoting Community Conversations About Research to End Suicide is the first listed.
NCT06658808 reports a single indexed study location in Alaska, Michigan.
Frequently Asked Questions
What is clinical trial NCT06658808 about?
NCT06658808 is a clinical study titled "Efficacy-Implementation Study for PC CARES in Rural Alaska". This participatory, pragmatic efficacy-implementation trial evaluates the impact of Promoting Community Conversations About Research to End Suicide (PC CARES) to evaluate Learning Circle (LC) participant outcomes (AIM#1), community-wide diffusion effects, and efficacy by tracking youth impact (AIM#2...
What is the current status of trial NCT06658808?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,075 participants. The study started on 2024-09-12. Estimated completion is 2031-05.
What conditions does trial NCT06658808 study?
This clinical trial studies the following conditions: Suicide Prevention.
What interventions are being tested in trial NCT06658808?
The interventions under investigation include: Promoting Community Conversations About Research to End Suicide (BEHAVIORAL).
Who is sponsoring clinical trial NCT06658808?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06658808 being conducted?
This trial has 2 study locations across Alaska, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06658808's enrollment target sits among peer trials
1,075 4th of 21 higher than 18 of 21 other Suicide Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Controlled Effectiveness Trial of VA S.A.V.E.
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Virtual Reality Lethal Means Safety Training
RECRUITING · NA
-
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
RECRUITING · NA
-
Suicide Prevention After Community Care Discharge
RECRUITING · NA
-
HAVEN-Connect Youth Suicide Prevention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07084883 · 1,076 participants
Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
- NCT06159673 · 1,074 participants · Phase 2
ACP-204 in Adults With Alzheimer's Disease Psychosis
- NCT06751043 · 1,072 participants · NA
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
- NCT06074068 · 1,080 participants · NA
Father-Focused Intervention for Reducing Family Violence and Symptoms in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI